MedTrace Logo

Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

NCT05621902 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 398

Last updated 2022-11-18

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate if weekly symptom monitoring of patients with advanced lung cancer is associated with better survival and improved quality of life compared to standard follow-up.

Each week, participants in the intervention group will be asked to respond to an electronic weekly questionnaire covering 11 items related to current health status.

Conditions

Interventions

OTHER

Weekly symptom monitoring

Patients randomized to the intervention arm will be invited to respond to a web-based weekly 11-item signs- and symptoms questionnaire

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER

  • Gävle Hospital

    collaborator OTHER

  • Mats Lambe

    lead OTHER

Principal Investigators

  • Gunnar L Wagenius, MD,PhD · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2025-06-30
Completion
2027-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621902 on ClinicalTrials.gov